Challenges in the diagnosis and management of renal artery stenosis.

Abstract

Renal artery stenosis (RAS) is a common cause of secondary hypertension, with the activation of the renin-angiotensin-aldosterone system being the pathophysiologic hallmark of the disease. Renovascular hypertension, ischemic nephropathy, proteinuria, and flash pulmonary edema are the main clinical syndromes associated with RAS. The prevalence of RAS is on the rise, owing to an increasing prevalence of diabetes and atherosclerotic disease among our aging population. This rise in RAS prevalence poses major challenges for clinicians making diagnostic and treatment decisions. Although renal angioplasty is of proven benefit in fibromuscular dysplasia, randomized trials in atherosclerotic RAS have not shown any advantage for revascularization over medical therapy in terms of blood pressure control or renal function preservation. Angioplasty and surgical interventions should be reserved for patients with preserved kidney size and hemodynamically significant stenosis.

• Authors: Moro O Salifu, Dhiren M Haria, Olurotimi Badero, Serhat Aytug, Samy I McFarlane
• Journal: Current hypertension reports (Curr Hypertens Rep) Vol. 7 Issue 3 Pg. 219-27 (Jun 2005) ISSN: 1522-6417 [Print] United States
• PMID: 15913498 (Publication Type: Journal Article, Review)

Chemical References

• Angiotensin-Converting Enzyme Inhibitors
• Antihypertensive Agents

Topics

• Angioplasty
• Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
• Antihypertensive Agents (therapeutic use)
• Diagnostic Imaging (methods)
• Humans
• Renal Artery Obstruction (complications, diagnosis, epidemiology, therapy)
• Stents